TCT
BIIB icon

TIAA CREF Trust’s Biogen BIIB Stock Holding History

TIAA CREF Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,108
Closed -$3.15M – 358
2016
Q4 		$3.15M Buy
11,108
+187
+2% +$55.4K 0.02% 158
2016
Q3 		$3.42M Sell
10,921
-3
-0% -$889 0.03% 145
2016
Q2 		$2.64M Sell
10,924
-21,826
-67% -$5.75M 0.02% 168
2016
Q1 		$8.53M Sell
32,750
-3,689
-10% -$974K 0.08% 101
2015
Q4 		$11.2M Buy
36,439
+5,317
+17% +$1.53M 0.11% 88
2015
Q3 		$9.08M Buy
31,122
+8,629
+38% +$2.85M 0.1% 95
2015
Q2 		$9.09M Buy
22,493
+6,594
+41% +$2.65M 0.1% 96
2015
Q1 		$6.71M Buy
15,899
+1,688
+12% +$665K 0.08% 117
2014
Q4 		$4.82M Buy
+14,211
New +$4.6M 0.06% 129

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TIAA CREF Trust's BIIB Position: Q1 2017 in Review

TIAA CREF Trust sold out of Biogen (BIIB) in Q1 2017, closing a stake of 11,108 shares — an estimated $3.15M sold.

TIAA CREF Trust first reported a position in BIIB in Q4 2014 and held it in 9 quarters. The position peaked at $11.2M in Q4 2015. 1,019 funds tracked by Wall St. Rank hold BIIB as of Q1 2017.

  • TIAA CREF Trust reported no remaining Biogen position as of Q1 2017 after selling out during the quarter.
  • TIAA CREF Trust sold 11,108 Biogen shares in Q1 2017, an estimated $3.15M.
  • TIAA CREF Trust first reported a position in Biogen in Q4 2014 and held it in 9 quarters.
  • TIAA CREF Trust's Biogen position peaked at $11.2M in Q4 2015.
  • 1,019 funds tracked by Wall St. Rank held Biogen as of Q1 2017.

Based on TIAA CREF Trust's 13F filing for Q1 2017, filed 3 May 2017.